Global Cord Blood (Global Cord Blood) Inventory-to-Revenue

: 0.16 (As of Mar. 2022)

View and export this data going back to 2007. Start your Free Trial

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Global Cord Blood's Average Total Inventories for the quarter that ended in Mar. 2022 was $7.3 Mil. Global Cord Blood's Revenue for the three months ended in Mar. 2022 was $46.8 Mil. Global Cord Blood's Inventory-to-Revenue for the quarter that ended in Mar. 2022 was 0.16.

Global Cord Blood's Inventory-to-Revenue for the quarter that ended in Mar. 2022 increased from Dec. 2021 (0.13) to Dec. 2021 (0.16)

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Global Cord Blood's Days Inventory for the three months ended in Mar. 2022 was 101.17.

Inventory Turnover measures how fast the company turns over its inventory within a year. Global Cord Blood's Inventory Turnover for the quarter that ended in Mar. 2022 was 0.90.

Global Cord Blood Inventory-to-Revenue Historical Data

The historical data trend for Global Cord Blood's Inventory-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Global Cord Blood Annual Data

Trend

Mar13

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Inventory-to-Revenue

Get a 7-Day Free Trial

0.03

0.04

Global Cord Blood Quarterly Data
	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22
Inventory-to-Revenue	Get a 7-Day Free Trial															0.17	0.13	0.11	0.13	0.16

Competitive Comparison

For the Diagnostics & Research subindustry, Global Cord Blood's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Global Cord Blood Inventory-to-Revenue Distribution

For the Medical Diagnostics & Research industry and Healthcare sector, Global Cord Blood's Inventory-to-Revenue distribution charts can be found below:

* The bar in red indicates where Global Cord Blood's Inventory-to-Revenue falls into.

Global Cord Blood Inventory-to-Revenue Calculation

Global Cord Blood's Inventory-to-Revenue for the fiscal year that ended in Mar. 2022 is calculated as

	Inventory-to-Revenue (A: Mar. 2022 )
=	Average Total Inventories					/	Revenue
=	( (Total Inventories (A: Mar. 2021 )	+	Total Inventories (A: Mar. 2022 ))	/	count )	/	Revenue (A: Mar. 2022 )
=	( (6.797	+	7.231)	/	2 )	/	195.955
=	7.014					/	195.955
=	0.04

Global Cord Blood's Inventory-to-Revenue for the quarter that ended in Mar. 2022 is calculated as

	Inventory-to-Revenue (Q: Mar. 2022 )
=	Average Total Inventories					/	Revenue
=	( (Total Inventories (Q: Dec. 2021 )	+	Total Inventories (Q: Mar. 2022 ))	/	count )	/	Revenue (Q: Mar. 2022 )
=	( (7.44	+	7.231)	/	2 )	/	46.844
=	7.3355					/	46.844
=	0.16

Global Cord Blood (OTCPK:CORBF) Inventory-to-Revenue Explanation

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.

More Related Terms:

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Global Cord Blood's Days Inventory for the three months ended in Mar. 2022 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Mar. 2022 )	/	Cost of Goods Sold (Q: Mar. 2022 )	*	Days in Period
	=	7.3355	/	6.616	*	365 / 4
	=	101.17

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Global Cord Blood's Inventory Turnover for the quarter that ended in Mar. 2022 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Mar. 2022 )	/	Average Total Inventories (Q: Mar. 2022 )
	=	6.616	/	7.3355
	=	0.90

Global Cord Blood Inventory-to-Revenue Related Terms

Thank you for viewing the detailed overview of Global Cord Blood's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Global Cord Blood (Global Cord Blood) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Global Cord Blood Corp (OTCPK:CORBF) » Definitions » Inventory-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

1 Garden Road, 48th Floor, Bank of China Tower, Central, Hong Kong, HKG

Website

http://www.globalcordbloodcorp.com

Global Cord Blood Corp provides cord blood banking services. The company provides cord blood processing and storage services for expectant parents interested in capturing the evolving medical treatments and technologies such as cord blood transplants.

Executives

Kent C Mccarthy	10 percent owner, other: Mbr 13(d) grp own 10% plus	930 TAHOE BLVD., 802-281, INCLINE VILLAGE NV 89451
Jayhawk Private Equity Fund Ii Lp	10 percent owner	5410 WEST 61ST PLACE, SUITE 100, MISSION KS 66205
7-2010 Grat 5 Under Kent C. Mccarthy Grat Tr Dtd 4-23-2010	other: 13 (d) group owning > 10%	7335 COTTONWOOD DRIVE, SHAWNEE KS 66216
7-2010 Grat 6 Under Kent C Mccarthy Grat Tr Dtd 4-23-2010	10 percent owner, other: Member of 13(d) group owning m	7335 COTTONWOOD, SHAWNEE KS 66216
Mccarthy Family Sd, Llc	10 percent owner, other: 13 (d) group owning > 10%	7335 COTTONWOOD DRIVE, SHAWNEE KS 66216
Jhab Fund Ii, Llc	other: 13(d) group owning > 10%	7335 COTTONWOOD DRIVE, SHAWNEE KS 66216
Jhab Management Ii, Llc	other: 13(d) group owning > 10%	7335 COTTONWOOD DRIVE, SHAWNEE KS 66216
Jcf Co Lf, L.p.	other: 13(d) group owning > 10%	930 TAHOE BLVD., 802-281, INCLINE VILLAGE NV 89451
Jayhawk Capital Management Llc	other: Member of the group	13021 W 74TH ST, SHAWNEE KS 66216
Jayhawk China Fund Cayman Ltd	other: Member of the group	930 TAHOE BLVD., 802-281, INCLINE VILLAGE NV 89451
Jayhawk Private Equity Gp Ii, L.p.	10 percent owner	5410 WEST 61ST PLACE, SUITE 100, MISSION KS 66205
Jayhawk Private Equity, Llc	10 percent owner	5410 WEST 61ST PLACE, SUITE 100, MISSION KS 66205